Insights from ELCC 2024
ELCC 2024 Insights: "ETOP ABC-Lung Trial - Atezo + Bev & Chemo in EGFRm NSCLC With Acquired Resistance"
By
Insights from ELCC 2024
FEATURING
Martin Früh
By
Insights from ELCC 2024
FEATURING
Martin Früh
Login to view comments.
Click here to Login
